53,572 Shares in Ingevity Co. (NYSE:NGVT) Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. acquired a new position in shares of Ingevity Co. (NYSE:NGVT - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 53,572 shares of the company's stock, valued at approximately $2,530,000. Assenagon Asset Management S.A. owned about 0.15% of Ingevity at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. FMR LLC lifted its position in shares of Ingevity by 15.7% during the third quarter. FMR LLC now owns 2,394 shares of the company's stock worth $114,000 after purchasing an additional 324 shares in the last quarter. Rockefeller Capital Management L.P. lifted its position in shares of Ingevity by 936.4% during the first quarter. Rockefeller Capital Management L.P. now owns 2,933 shares of the company's stock worth $209,000 after purchasing an additional 2,650 shares in the last quarter. Pathstone Family Office LLC lifted its position in shares of Ingevity by 22.1% during the third quarter. Pathstone Family Office LLC now owns 4,430 shares of the company's stock worth $211,000 after purchasing an additional 803 shares in the last quarter. Mariner LLC acquired a new position in shares of Ingevity during the fourth quarter worth approximately $224,000. Finally, Two Sigma Investments LP acquired a new position in shares of Ingevity during the first quarter worth approximately $250,000. 91.59% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company upped their target price on shares of Ingevity from $43.00 to $50.00 and gave the stock an "equal weight" rating in a research report on Friday, February 23rd. Five research analysts have rated the stock with a hold rating, According to MarketBeat, Ingevity presently has a consensus rating of "Hold" and a consensus target price of $48.75.

Ingevity Price Performance

NGVT stock traded down $0.74 during trading on Thursday, reaching $46.45. 186,318 shares of the company were exchanged, compared to its average volume of 232,110. The company has a debt-to-equity ratio of 2.19, a current ratio of 1.81 and a quick ratio of 0.96. Ingevity Co. has a twelve month low of $36.66 and a twelve month high of $74.74. The company has a 50-day moving average of $45.84 and a two-hundred day moving average of $43.71. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of -211.14 and a beta of 1.85.

Ingevity (NYSE:NGVT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 21st. The company reported $0.21 EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.34. Ingevity had a negative net margin of 0.32% and a positive return on equity of 20.75%. The company had revenue of $371.70 million for the quarter, compared to analyst estimates of $336.74 million. During the same period in the prior year, the firm posted $0.57 EPS. The company's quarterly revenue was down 3.1% on a year-over-year basis. As a group, equities analysts predict that Ingevity Co. will post 3.65 earnings per share for the current fiscal year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.